SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer.

Váncza, Lóránd; Horváth, Anna; Seungyeon, Lee; Rókusz, András; Dezso, Katalin; Reszegi, Andrea; Petovári, Gábor; Götte, Martin; Kovalszky, Ilona; Baghy, Kornélia

Váncza, Lóránd; Horváth, Anna; Seungyeon, Lee; Rókusz, András; Dezso, Katalin; Reszegi, Andrea; Petovári, Gábor; Götte, Martin; Kovalszky, Ilona; Baghy, Kornélia.

Afiliación

Váncza L; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Horváth A; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Seungyeon L; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Rókusz A; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Dezso K; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Reszegi A; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, 1085 Budapest, Hungary.
Petovári G; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Götte M; Department of Gynecology and Obstetrics, University Hospital Münster, 48149 Münster, Germany.
Kovalszky I; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Baghy K; Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.

Cancers (Basel) ; 15(7)2023 Mar 29.

Article en En | MEDLINE | ID: mdl-37046698

Palabras clave

SPOCK1; extracellular matrix; ovarian cancer; proteoglycan; testican-1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google